The global Lacrimal Devices Industry is experiencing a remarkable growth trajectory, as it is expected to reach a value of US$ 39.7 million by the end of 2029. This growth is driven by a consistent sales revenue increase, boasting a remarkable Compound Annual Growth Rate (CAGR) of 5.5%. The market value, which stood at approximately US$ 25.6 million in 2021, reflects the sustained expansion of this dynamic industry.
Innovative Lacrimal Devices Pave the Way for Tear Drainage Solutions
Lacrimal devices, including Nasolacrimal stents, are innovative small tubes that provide a novel channel for tears to drain. These devices come to the rescue when traditional tear ducts fail, and alternative drainage mechanisms are not available, offering an essential bypass path for tear drainage. The historical evolution of lacrimal devices traces back to the pioneering work of Dr. Graue, who introduced the first described stent made of silver wire back in 1932. Over the years, various materials such as silk, nylon, polyethylene, and polypropylene have been employed, with modern tubes typically crafted from silicone or similar semi-rigid, yet flexible materials, featuring an open center lumen.
Request a Sample Copy of the Report Now.
https://www.futuremarketinsights.com/reports/sample/rep-gb-9649
The increased demand for ophthalmic treatments with greater success rates and minimum intrusions, as well as an increase in patients with nasolacrimal duct obstruction, are driving the worldwide lacrimal devices market.
During the projected period, the introduction of innovative and high-success-rate treatments will move the market forward. Adoption of precise and updated lacrimal devices, such as the new lacrimal cannula, which combines flexibility and strength to prevent trauma by providing easy access to the canaliculus, is a fundamental driver of market expansion.
Manufacturers Emphasizing Advanced Product Development
Numerous organizations are focusing on new product development for lacrimal duct stent tube. In June 2019, FCI Ophthalmic offered a complete line of BIKA stents namely, BIKA, BIKA for DCR, and Infant BIKA covering a range of sizes that will benefit most of the congenital nasolacrimal duct obstruction (CNLDO) and dacryocystorhinostomy (DCR) cases.
Get Your Customized Impactful Report Now!
https://www.futuremarketinsights.com/customization-available/rep-gb-9649
Key Takeaways – Lacrimal Duct Stent Tube Market Study
- Bicanalicular lacrimal duct stent tube is expected to contribute three fourth of revenue share in the lacrimal duct stent tube market owing to its high success rate in stent placement.
- Hospitals captured maximum share of the lacrimal duct stent tube market owing to highest patient footfall followed by ophthalmic clinics.
- Attributed to growing patient pool for retinal diseases, especially due to premature births, contributed to the dominance of North America in the lacrimal duct stent tube market.
- Increasing awareness for availability of the treatment for nasolacrimal duct stent obstruction among caregivers of prematurely born babies and increasing number of skilled professionals are expected to drive growth of the lacrimal duct stent tube market in East Asia.
Competitive Landscape
- FCI Ophthalmics
- Kaneka Corporation (Kaneka Pharma America LLC)
- Gunther Weiss Scientific Glass
- Bess Medizintechnik GmBH
Shedding light on the study’s key assumptions. Ask an analyst now.
https://www.futuremarketinsights.com/ask-question/rep-gb-9649
Key Market Segments Covered In Lacrimal Devices Industry Research
By Product:
- Monocanalicular Lacrimal Duct Stent Tube
- Bicanalicular Lacrimal Duct Stent Tube
By End User:
- Hospitals
- Ophthalmic Clinics
- Ambulatory Surgical Centers
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5,000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
